Tag: Biolinq
Biosensor tech company secures $100M investment
April 22, 2025HME News Staff
SAN DIEGO – Biolinq, a healthcare technology company of biosensors, has received a $100 million Series C financing led by Alpha Wave Ventures, with participation from existing investors RiverVest Venture Partners, AXA IM Alts, LifeSci Venture Partners, M Ventures, Hikma Ventures, Aphelion Capital, Taisho Pharmaceutical and Features Capital. The funding will support Biolinq through the US regulatory approval process as the company prepares to bring the first autonomous intradermal glucose sensor...
Biolinq, biosensor, Glucose monitoring, wearables
Sponsored Stories
Unlock the Future of Your Business: Download the VGM Playbook for 2025!
By VGM & AssociatesExclusive Look: The SOS Philippines Team in Action! (Watch the Video)
By Strategic Office SupportFrom Intake to Billing — SOS Handles It All for HME/DME Providers
By Strategic Office Support